Valuation: CellaVision AB

Market Cap 3.51B 364M 318M 294M 271M 510M 35.08B 522M 1.38B 17.18B 1.37B 1.34B 59.14B P/E 2026 *
25.2x
P/E 2027 * 20.2x
Enterprise Value 3.29B 342M 299M 276M 254M 479M 32.91B 489M 1.3B 16.12B 1.28B 1.26B 55.49B EV / Sales 2026 *
4.17x
EV / Sales 2027 * 3.79x
Free-Float
83.08%
Yield 2026 *
1.87%
Yield 2027 * 2.17%
1 day+7.76%
1 week+6.36%
Current month+8.08%
1 month+4.25%
3 months-8.91%
6 months-8.00%
Current year-6.36%
1 week 131.8
Extreme 131.8
153
1 month 131.8
Extreme 131.8
153
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 70.5
Extreme 70.5
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 2018-05-03
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap.
6/12/26 Buy 760 0.0032%
6/9/26 Buy

Director

314 0.0013%
6/9/26 Buy

Founder

33,000 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
+7.76%+6.36%-18.49%-20.78% 364M
-1.46%+0.58%+15.63%-20.90% 17.27B
-6.27%-7.01%-0.94%+86.29% 1.57B
-4.71%-4.87%-34.86%-79.09% 1.19B
-1.34%-5.93%-37.77%+12.26% 999M
-4.06%+2.84%-29.00%-52.37% 644M
-7.46%-4.05%-40.81%-57.53% 532M
-1.95%-4.52%+34.39%-53.87% 445M
-1.26%+0.64%-54.16%-58.79% 382M
-3.29%+9.05%+44.40% - 331M
Average -2.40%-0.30%-12.16%-27.20% 2.37B
Weighted average by Cap. -2.03%-0.22%+6.39%-18.20%

Financials

2026 *2027 *
Net sales 789M 81.86M 71.54M 66.01M 60.85M 115M 7.88B 117M 310M 3.86B 307M 301M 13.29B 857M 88.94M 77.73M 71.73M 66.11M 125M 8.57B 127M 337M 4.2B 334M 327M 14.44B
Net income 140M 14.49M 12.66M 11.68M 10.77M 20.29M 1.4B 20.75M 54.92M 683M 54.4M 53.21M 2.35B 174M 18.03M 15.75M 14.54M 13.4M 25.25M 1.74B 25.82M 68.34M 850M 67.7M 66.21M 2.93B
Net Debt -217M -22.5M -19.67M -18.15M -16.73M -31.53M -2.17B -32.23M -85.31M -1.06B -84.51M -82.66M -3.65B -258M -26.75M -23.38M -21.57M -19.88M -37.48M -2.58B -38.31M -101M -1.26B -100M -98.26M -4.34B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Date Price Change Volume
26-07-17 SEK 147.20 +7.76% 88,649
26-07-16 SEK 136.60 +0.89% 12,521
26-07-15 SEK 135.40 +0.74% 25,981
26-07-14 SEK 134.40 -2.89% 32,098
26-07-13 SEK 138.40 0.00% 21,004
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
147.20SEK
Average target price
173.00SEK
Spread / Average Target
+17.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock